Stay updated with breaking news from Delta Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in ChinaThe amu...
Brii Biosciences Announces Commercial Launch of its Amubarvimab/Romlusevimab Combination Therapy for COVID-19 in China - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for...
/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for...
/PRNewswire/ -- Verified Market Research recently published a report, "Personal Protective Equipment Kit Market" By Product (Hands And Arm Protection, Foot And...